Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer

Our results strongly suggest that clinical examination of the expression of both KMT2C and SLC20A1 in ER+ breast cancer will be very useful for the determination of prognosis and therapy.